Low-dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndromes (LILACS): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase I/II clinical trial. (2018)

First Author: Zhao TX
Attributed to:  Adaptive Clinical Trials funded by MRC


No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2018-022452

PubMed Identifier: 30224390

Publication URI: http://europepmc.org/abstract/MED/30224390

Type: Journal Article/Review

Volume: 8

Parent Publication: BMJ open

Issue: 9

ISSN: 2044-6055